These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29070437)

  • 1. Factors associated with diabetic nephropathy in children, adolescents, and adults with type 1 diabetes.
    Huang CY; Ting WH; Lo FS; Tsai JD; Sun FJ; Chan CI; Chiang YT; Lin CH; Cheng BW; Wu YL; Hung CM; Lee YJ
    J Formos Med Assoc; 2017 Dec; 116(12):924-932. PubMed ID: 29070437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetes.
    Bezen D; Vurgun E; Dursun H
    Pediatr Nephrol; 2023 Nov; 38(11):3693-3698. PubMed ID: 37204490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control in patients with type I diabetes and normoalbuminuria after long diabetes duration.
    Kullberg CE; Arnqvist HJ
    J Diabetes Complications; 1997; 11(3):151-7. PubMed ID: 9174895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audit of microalbumin excretion in children with type I diabetes.
    Cizmecioğlu FM; Noyes K; Bath L; Kelnar C
    J Clin Res Pediatr Endocrinol; 2009; 1(3):136-43. PubMed ID: 21274398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the relationship between short-term glycemic control and netrin-1, a urinary proximal tubular injury marker in children with type 1 diabetes.
    Uçaktürk SA; Mengen E; Elmaoğulları S; Yücel Ç; A Yılmaz A; Çifci A
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):851-856. PubMed ID: 31219796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of lymphocyte count in autoimmune diabetic nephropathy.
    Xiang Z; Liu W; Fu S; Hu J; Yang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1639-1649. PubMed ID: 38432854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus.
    Krairittichai U; Potisat S; Jongsareejit A; Sattaputh C
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S1-5. PubMed ID: 21717870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria.
    Chen WZ; Hung CC; Wen YW; Ning HC; Gau BR; Huang YY
    Ren Fail; 2014 Mar; 36(2):171-5. PubMed ID: 24028605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of urinary albumin excretion in young diabetic patients--Wessex Diabetic Nephropathy Project.
    Twyman S; Rowe D; Mansell P; Schapira D; Betts P; Leatherdale B;
    Diabet Med; 2001 May; 18(5):402-8. PubMed ID: 11472452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes.
    Mamilly L; Mastrandrea LD; Mosquera Vasquez C; Klamer B; Kallash M; Aldughiem A
    Front Endocrinol (Lausanne); 2021; 12():669954. PubMed ID: 33995287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT).
    Marcovecchio ML; Chiesa ST; Armitage J; Daneman D; Donaghue KC; Jones TW; Mahmud FH; Marshall SM; Neil HAW; Dalton RN; Deanfield J; Dunger DB;
    Diabetes Care; 2018 Sep; 41(9):1963-1969. PubMed ID: 30026334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.